Emerging Markets Earnings Roundup: Bayer HealthCare (Part 8)
This article was originally published in PharmAsia News
Bayer HealthCare surges ahead in Asia-pacific in the first quarter with the pharmaceutical and over the counter segments in close focus for the company as it ramps up activity across the region.
You may also be interested in...
The diversified German big pharma highlighted the sales growth of its five recently launched drugs in the first quarter, but declined to fuel M&A speculation surrounding its non-life sciences division.
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.